CT-2000

N/A

Report date: 2026/04/03 20:03:44
NME

Base Information

Drug NameCT-2000
Drug Alias NameCT-2000CT2000CC8464
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel protein type IX alpha subunit inhibitors
TargetsSodium channel protein type IX alpha subunit
Therapy Area/IndicationsEye PainXerophthalmia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesChannel Therapeutics Corp
China Registration ClassN/A

Develop Information

Active CompaniesChannel Therapeutics Corp
Inactive CompaniesN/A
Active IndicationsEye Pain
Inactive IndicationsXerophthalmia

Other Information

ATC CodeN/A
Related LinksN/A